To investigate whether ABCA1/ApoE mediates GW3965-induced neurorestoration after stroke, ABCA1fl/fl and ABCA1−B/−B stroke mice were randomly divided into 4 groups by a non-team member using the method of drawing different colored balls. Mice were gavaged starting 24h after dMCAo with saline as vehicle control or GW3965 10mg/kg (Sigma) daily for 14 days based on previous dose-dependent study10 (link). After 14 days of treatment, animals were randomly separated into two sets: one set of animals (total 24 mice, n=6/group) were employed for WB and RT-PCR assay; the other set of animals (total 36 mice, n=9/group) were used for behavioral testing, blood-biochemistry, and lesion-volume and immunostaining measurements.
To investigate the effect of HDL on GW3965-induced neurorestoration, ABCA1−B/−B stroke mice were randomly assigned to two groups (total 18 mice, n=9/group) and intraventricularly-infused with artificial cerebrospinal-fluid (CSF, Tocris Bioscience) 100μl as vehicle control, or human-plasma HDL3 (hHDL3, Cell Biolabs Inc.) 25μg in 100μl artificial-CSF by transplanting a micro-osmotic pump (D1002, Alzet) into the right lateral-ventricle initiated at 24h after dMCAo for 14 days. All mice were sacrificed 14 days after dMCAo.